Company

Welcome to GSK Belgium

Belgium hosts 3 main vaccine sites for GSK (in Wavre, Rixensart and Gembloux), including the historical centre of the vaccines of the group. This makes us the largest industrial network of vaccines in the world.

Our purpose

We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.​ Our research & development (R&D) focus is on four therapeutic areas: (1) respiratory, immunology and inflammation, (2) oncology, (3) HIV, and (4) infectious diseases.​

GSK Belgium
9,000
employees on our 3 sites (Wavre, Rixensart, Gembloux).
Innovation and R&D
1.5 billion
€ invested in research and development in Belgium in 2023.
Vaccines
17
candidate vaccines in R&D.

Ahead together

Scientist pouring a liquid into a machine

Innovation

group of children

Responsibility

Un scientifique écrit sur une feuille dans un laboratoire

Clinical trials

pinch icon pinch icon

Bloodcells Anaemia illustration

Our global "Behind the science" magazine

Discover and read our latest innovations in our global "Behind the science" magazine.